UNIQURE ($QURE) posted quarterly earnings results on Tuesday, July 29th. The company reported earnings of -$0.69 per share, beating estimates of -$0.91 by $0.22. The company also reported revenue of $5,260,000, missing estimates of $5,842,560 by $-582,560.
You can see Quiver Quantitative's $QURE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
UNIQURE Insider Trading Activity
UNIQURE insiders have traded $QURE stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $QURE stock by insiders over the last 6 months:
- MATTHEW C KAPUSTA (CEO, Managing Director) has made 0 purchases and 3 sales selling 61,785 shares for an estimated $653,644.
- CHRISTIAN KLEMT (Chief Financial Officer) has made 0 purchases and 3 sales selling 27,695 shares for an estimated $293,864.
- JEANNETTE POTTS (Chief Legal Officer) has made 0 purchases and 2 sales selling 11,746 shares for an estimated $143,515.
- ROBERT GUT sold 3,336 shares for an estimated $48,205
- WALID ABI-SAAB (Chief Medical Officer) has made 0 purchases and 2 sales selling 2,816 shares for an estimated $34,298.
- LEONARD E POST sold 2,112 shares for an estimated $30,518
- JACK KAYE sold 2,112 shares for an estimated $30,518
- DAVID D. MEEK sold 2,112 shares for an estimated $30,518
- MADHAVAN BALACHANDRAN sold 2,112 shares for an estimated $30,518
- JEREMY P. SPRINGHORN sold 2,112 shares for an estimated $30,518
- RACHELLE SUZANNE JACQUES sold 2,112 shares for an estimated $30,518
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
UNIQURE Hedge Fund Activity
We have seen 69 institutional investors add shares of UNIQURE stock to their portfolio, and 64 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RTW INVESTMENTS, LP added 3,361,803 shares (+372.0%) to their portfolio in Q1 2025, for an estimated $35,635,111
- VESTAL POINT CAPITAL, LP added 1,767,572 shares (+58.4%) to their portfolio in Q1 2025, for an estimated $18,736,263
- POINT72 ASSET MANAGEMENT, L.P. removed 1,641,277 shares (-92.7%) from their portfolio in Q1 2025, for an estimated $17,397,536
- STATE STREET CORP added 1,037,056 shares (+538.6%) to their portfolio in Q1 2025, for an estimated $10,992,793
- CITADEL ADVISORS LLC added 773,314 shares (+6441.1%) to their portfolio in Q1 2025, for an estimated $8,197,128
- MARSHALL WACE, LLP removed 670,187 shares (-91.9%) from their portfolio in Q1 2025, for an estimated $7,103,982
- STEMPOINT CAPITAL LP added 641,039 shares (+712.3%) to their portfolio in Q1 2025, for an estimated $6,795,013
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UNIQURE Analyst Ratings
Wall Street analysts have issued reports on $QURE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Chardan Capital issued a "Buy" rating on 05/30/2025
- HC Wainwright & Co. issued a "Buy" rating on 05/29/2025
- Guggenheim issued a "Buy" rating on 05/12/2025
To track analyst ratings and price targets for UNIQURE, check out Quiver Quantitative's $QURE forecast page.
UNIQURE Price Targets
Multiple analysts have issued price targets for $QURE recently. We have seen 4 analysts offer price targets for $QURE in the last 6 months, with a median target of $34.0.
Here are some recent targets:
- Daniil Gataulin from Chardan Capital set a target price of $38.0 on 05/30/2025
- Patrick Trucchio from HC Wainwright & Co. set a target price of $70.0 on 05/29/2025
- Debjit Chattopadhyay from Guggenheim set a target price of $28.0 on 05/12/2025
- Yanan Zhu from Wells Fargo set a target price of $30.0 on 02/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
